Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1,800,000 Profiles
- More than 3,500 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
find experts for
Sign-in to see more
2005:
Check J H; Liss J R; Diantonio A; Check M L; Duroseau M
Matched control study of efficacy of lymphocyte immunotherapy in donor oocyte recipients to support or refute the concept of need for histocompatibility antigen sharing of the couple for benefits.
Clinical and experimental obstetrics & gynecology 2005;
32(
3):.
PURPOSE: To determine if lymphocyte immunotherapy (LIT) improves outcome in recalcitrant donor oocyte recipients. If LIT was found to be similarly effective in this group, the theory of shared maternal/paternal histocompatibility antigens would seem less plausible because the donor oocyte introduces another group of histocompatibility antigens. METHODS: Donor oocyte recipients with a history of failure to conceive despite at least two previous ETs using donor oocytes were given the option of having LIT. They were matched with the very next recipient who declined LIT therapy. Lymphocyte immunotherapy using the male partner's lymphocytes was given two weeks before transfer and twice more if pregnant. RESULTS: Only three controls delivered versus recipients treated with LIT. CONCLUSIONS: The fact that benefit from LIT extended to oocyte recipients challenges the concept that lymphocyte immunotherapy is most beneficial for couples sharing histocompatibility antigens.
Post to CiteULike 
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
